Surgery Partners stockSGRY
Surgery Partners trades at $23.17, 0.9% below its 52-week high (Oct 27, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +50.0% year to date, +5.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 10, 2026.
Ratings, candles, signals and the screener for SGRY — after you log in
Open the terminalFrequently asked questions about Surgery Partners
What is the Surgery Partners stock price?
At the close on Nov 5, 2026: $23.17 (+0.04% on the day). 52-week high: $23.37 on Oct 27, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Surgery Partners report earnings?
The next quarterly report is on Nov 10, 2026. Last quarter, earnings per share changed −41% year over year, revenue +3%.
Does Surgery Partners pay dividends?
No, Surgery Partners does not pay dividends.
Where does Surgery Partners trade and how to buy it?
Ticker SGRY, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy Surgery Partners now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for SGRY are in the terminal after you log in.